Skip to content

Quantra QPlus System KT-0025

by Hemosonics LLC

Quantra QPlus System KT-0025 is a Class II device made by Hemosonics LLC, granted FDA De Novo DEN180017 on 12 Mar 2019 and listed in FDA GUDID since 11 Feb 2021 (UDI-DI 00850003761275), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

De Novo DEN180017

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850003761275 UDI-DI Date11 Feb 2021ListedStatusListed GUDID: in commercial distribution
United StatesFDA De NovoDENG from GUDID De Novo granted · Direct NumberDEN180017 Date12 Mar 2019DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA De Novo DEN180017 decided 12 Mar 2019 Active
  • FDA GUDID UDI-DI 00850003761275 listed 11 Feb 2021 Listed

Timeline

2 dated events

  1. Granted FDA De Novo DEN180017
  2. Listed FDA GUDID 00850003761275

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

GUDID

Trade name
Quantra QPlus System
Generic name
Coagulation analyser IVD, point-of-care, line-powered
Model / reference
KT-0025
Primary DI / UDI-DI
00850003761275
De Novo Number
FDA product code
QFR
GMDN term
Coagulation analyser IVD, point-of-care, line-powered
Device class
Class II
Regulation number
864.5430
GUDID distribution status
In Commercial Distribution

Other devices from Hemosonics LLC

See all devices from Hemosonics LLC →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (9, all answered No)